Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 61

    Cancer drug Alunbrig compared to Xalkori shows longer benefit, says Takeda Pharma

    Cancer drug Alunbrig compared to Xalkori shows longer benefit, says Takeda Pharma

    Medical Dialogues Bureau26 Nov 2019 9:00 AM IST
    Alunbrig, Takeda Pharma's trade name of Brigatinib, reduced the risk of disease progression by 76% in patients whose cancer had spread to the brain...
    CDSCO declares 36 samples of Atorvastatin, Metformin, Paracetamol, others as Not of Standard Quality

    CDSCO declares 36 samples of Atorvastatin, Metformin, Paracetamol, others as Not of Standard Quality

    Farhat Nasim25 Nov 2019 3:41 PM IST
    New Delhi: The nodal drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared batches of 36 drugs as not of standard...
    Torrent Pharma pulled up by USFDA for significant violations at US plant

    Torrent Pharma pulled up by USFDA for significant violations at US plant

    Medical Dialogues Bureau25 Nov 2019 12:15 PM IST
    In a warning letter issued to Torrent Pharma Inc's CEO Sanjay Gupta, the US Food and Drug Administration (USFDA) said its inspectors found significant...
    Unichem Labs gets USFDA nod for generic version of Tenormin tablets

    Unichem Labs gets USFDA nod for generic version of Tenormin tablets

    Farhat Nasim25 Nov 2019 9:45 AM IST
    Unichem Labs said Atenolol tablets USP is a generic version of TENORMIN (Atenolol) Tablets, 25 mg, 50 mg, and 100 mg, of Alvogen Malta Operations...
    India, China spar over legacy of Sowa-Rigpa, medicinal system similar to Ayurveda

    India, China spar over legacy of Sowa-Rigpa, medicinal system similar to Ayurveda

    Medical Dialogues Bureau25 Nov 2019 9:33 AM IST
    “India has approached Unesco seeking the enlisting of the Sowa Rigpa as its ‘intangible cultural heritage’. China has raised an objection to it,” an...
    Lupin launches generic Potassium Chloride for oral solution USP post USFDA nod

    Lupin launches generic Potassium Chloride for oral solution USP post USFDA nod

    Farhat Nasim25 Nov 2019 9:15 AM IST
    Mumbai: Pharma major Lupin Limited (Lupin) recently announced the launch of Potassium Chloride (KCl) for Oral Solution USP, 20 mEq, having received an...
    Tecentriq-Avastin cocktail helps liver cancer patients live longer: Roche

    Tecentriq-Avastin cocktail helps liver cancer patients live longer: Roche

    Medical Dialogues Bureau25 Nov 2019 9:00 AM IST
    Median overall survival for patients with unresectable hepatocellular carcinoma (HCC), or that which cannot be surgically removed, getting Tecentriq...
    NPPA fixes ceiling price of Zydus Cadila Tiotropium post DoP orders

    NPPA fixes ceiling price of Zydus Cadila Tiotropium post DoP orders

    Farhat Nasim24 Nov 2019 3:00 PM IST
    New Delhi: In an implementation of directions given in line with review orders issued by the Department of Pharmaceuticals (DOP), the apex drug price...
    Producers of anti-venom, anti-toxin drugs respond to PETA PIL in Delhi High Court

    Producers of anti-venom, anti-toxin drugs respond to PETA PIL in Delhi High Court

    Medical Dialogues Bureau24 Nov 2019 11:30 AM IST
    New Delhi: Companies manufacturing anti-venom and anti-toxins by using horses and mules have told the Delhi High Court that exploring alternatives to...
    FIRST: Lupin launches Adhero, smart device to support treatment of respiratory disease in India

    FIRST: Lupin launches Adhero, smart device to support treatment of respiratory disease in India

    Farhat Nasim24 Nov 2019 10:15 AM IST
    Mumbai: Pharma major Lupin Limited (Lupin) recently announced the launch of “ADHERO,” a new connected smart device for metered-dose inhalers. This...
    AstraZeneca leukemia drug Calquence gets USFDA okay

    AstraZeneca leukemia drug Calquence gets USFDA okay

    Medical Dialogues Bureau24 Nov 2019 10:00 AM IST
    New Delhi: AstraZeneca said late on Thursday that the U.S. Food and Drug Administration (FDA) had given its go-ahead for the company's Calquence drug...
    CNS Pharma acquires worldwide rights for brain cancer drug Berubicin from Houston Pharma

    CNS Pharma acquires worldwide rights for brain cancer drug Berubicin from Houston Pharma

    Medical Dialogues Bureau24 Nov 2019 9:20 AM IST
    CNS Pharma intends to apply for orphan drug status for Berubicin with the FDA for the treatment of malignant glioma.New Delhi: CNS Pharmaceuticals, a...
    PrevNext

    Popular Stories

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    Top Pharmacy Courses That Rule the Industry

    Top Pharmacy Courses That Rule the Industry

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Google CEO Sundar Pichai calls for regulation of AI

    Google CEO Sundar Pichai calls for regulation of AI

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok